Hepcidin is an antimicrobial peptide hormone involved in the metabolism of iron, encoded for by the HAMP gene mainly in hepatocytes. It's expressed at lower levels in other cells such as the macrophages. The mechanisms that determine tissue-specific expression of hepcidin remain unclear. GATA-and its co-factor Friend of GATA (FOG) modulate the tissue-specific transcription of other genes involved in the metabolism of iron. GATA proteins are group of evolutionary conserved transcriptional regulators that bind to the consensus motif -WGATAR-in the promoter. We characterized a 1 . 3 kb fragment of the 5 0 -flanking sequence of the HAMP gene in Huh7 cells, which express HAMP. Transfection of 5 0 -deletions of the HAMP promoter in Huh7 cells revealed two regions, K932/K878 and K155/K96, that when deleted decreased promoter activity. Using site-directed mutations in the HAMP promoter region K155/K96 we identified two subregions, K138/K125 and K103/K98, which when mutated suppressed promoter activity by 70 and 90% respectively. Site K103/K98 with a sequence -TTATCT-to which endogenous GATA proteins 4 and 6 bind and transactivate HAMP is a GATA-regulatory element (RE). Mutation of the GATA-RE abrogated binding of GATA proteins 4 and 6 to the promoter and blunted the GATA transactivation of HAMP. FOG proteins 1 and 2 suppressed the endogenous and exogenous GATA activation of the HAMP promoter. We concluded that the GATA-RE, -TTATCT-in the HAMP promoter region K103/K98 is crucial for the GATA-4 and GATA-6 driven transcription of hepcidin in Huh7 cells and that FOG proteins moderate the transcription by suppressing the GATA transactivation of HAMP.
Introduction
The concentration of iron in the body is regulated by an antimicrobial peptide hormone, hepcidin, which is encoded by the HAMP gene that is expressed mainly in the liver by hepatocytes (Roetto et al. 2003 , Pietrangelo 2006 . Hepcidin is also expressed at lower levels in other organs such as the heart, brain, spinal cord, stomach, and pancreas and in cells such as adipocytes and macrophages (Merle et al. 2007 , Kulaksiz et al. 2008 , Hanninen et al. 2009 , Isoda et al. 2010 . Increases in the concentration of iron and inflammation upregulate the transcription of hepcidin, while iron deficiency and hypoxia downregulate it (Nicolas et al. 2002) . At present, it is unclear as to what the molecular mechanisms involved in the tissue-specific expression of hepcidin are.
Studies on the HAMP promoter indicate that the region K235/C50 bp is crucial for the basal expression of hepcidin in hepatocytes, since mutation of the CCAAT/enhancer-binding protein (C/EBP) site K231/K222 (Courselaud et al. 2002) , cyclic AMP response element-binding protein (CREB) site K138/K131 (Vecchi et al. 2009 ), bone morphogenetic protein-response element (BMP-RE) site K84/K79 (Verga Falzacappa et al. 2008) , and signal transducer and activator of transcription 3-response element (STAT3-RE) site K72/K64 (Pietrangelo et al. 2007 , Verga Falzacappa et al. 2007 in this region abrogate the basal transcription of HAMP.
In hepatocytes, GATA-and its co-factor Friend of GATA (FOG) modulate the tissue-specific transcription of other genes involved in the metabolism of iron, in particular: GATA-1 is a transcriptional enhancer of hemochromatosis (HFE; Mura et al. 2004 ) and erythropoietin receptor (EPOR; Chiba et al. 1991) ; GATA proteins 2 and 3 are transcriptional repressors of EPO; while GATA-4 is a transcriptional activator of EPO (Imagawa et al. 1997 , Dame et al. 2004 , Obara et al. 2008a .
GATA proteins are evolutionarily conserved cellspecific transcriptional regulators that bind to the consensus motif -WGATAR-in the promoter region of several genes (Ko & Engel 1993) . Six GATA-factors with a highly conserved zinc finger DNA-binding domain have been identified (Weiss & Orkin 1995 , Molkentin 2000 . In hepatocytes, GATA-1, GATA-4, and GATA-6 are expressed in the prenatal period; while GATA-2, GATA-3, and GATA-6 in the postnatal period (Dame et al. 2004 , Divine et al. 2004 . In mice, the disruption of either the GATA-4 or GATA-6 gene results in embryonic death, due to defects in formation of either the heart tube or extra-embryonic endoderm respectively (Kuo et al. 1997 , Molkentin et al. 1997 , Zhao et al. 2005 . GATA proteins regulate the expression of other genes through functional interactions with FOGproteins (Robert et al. 2002 , Obara et al. 2008a .
At present, two FOG proteins have been identified: FOG-1, mainly expressed in erythroid and megakaryocytic cells (Tsang et al. 1997) and FOG-2 in the heart, brain, and gonads (Lu et al. 1999 , Svensson et al. 1999 , Tevosian et al. 1999 and at low levels in the liver (Lu et al. 1999) . FOG-1 knockout mice die in midgestation from anemia and cessation in erythroid maturation (Tsang et al. 1998) ; while FOG-2 knockout mice exhibit cardiovascular defects leading to embryonic death (Tevosian et al. 1999 , Svensson et al. 2000b .
In this study, we identified a GATA-RE, -TTATCT-in the HAMP promoter region K103/K98 that is crucial for the FOG (1 and 2) repression of the endogenous and exogenous GATA (4 and 6) transactivation of HAMP.
Materials and methods

Cell culture
HepG2 cells were cultured as recommended by American Type Culture Collection (Manassas, VA, USA); while Huh7 cells (gift from Dr K Pantopoulos) were cultured in DMEM essential medium (WISENT, Inc., Montreal, QC, Canada) supplemented with 10% heat inactivated fetal bovine serum (WISENT, Inc.), 1% non-essential amino acids (WISENT, Inc.), 50 mg/ml of penicillin-streptomycin (WISENT, Inc.), and 0 . 5 mg/ml amphotericin B (WISENT, Inc.). Huh7 and HepG2 cells were incubated at 37 8C under 5% CO 2 .
RNA isolation, reverse transcription, PCR, and real-time PCR Total RNA from hepatocytes was isolated using TRizol as recommended by the manufacturer (Invitrogen Canada). The RNA (2 mg) was used as a template to synthesize the first-strand cDNA using Omniscript reverse transcriptase-PCT (RT-PCR) system (Qiagen). The first-strand cDNA synthesized (20 ml) was diluted to 120 ml with RNase-free water, 5 ml of which was used as a template in quantitative RT-PCRs. Adult human liver total RNA was purchased from Clontech Laboratories, Inc. Quantification of gene expression was performed by a Rotor Gene 3000 Real-time DNA Detection System (Montreal Biotech, Kirkland, QC, Canada) with QuantiTect SYBRGreen I PCR kits (Qiagen), as described previously (Constante et al. 2007) . The oligonucleotides used to amplify b-actin, HAMP, GATA-2, GATA-3, GATA-4, GATA-6, FOG-1, and FOG-2 genes are listed in Table 1 . The PCR products were confirmed by agarose gel electrophoresis and sequencing (University McGill and Génome Québec Innovation Centre, Montréal QC). Gene expression levels in the liver tissue or hepatoma cells were represented relative to the expression of the housekeeping gene b-actin.
Plasmids
A 1307 bp fragment (K1234/C73) of the 5 0 -flanking end of the HAMP gene was generated from human genomic DNA by PCR using the primers listed in Table 1 . Deletion constructs (K1117, K932, K878, K816, K155, and K96 bp) were generated using primers listed in Table 1 and the HAMP plasmid K1234/C73 bp as a template. All the promoter fragments were cloned into a modified pXP1 luciferase reporter plasmid obtained from Dr Jacques Tremblay (CHUQ, Laval University, Quebec, Canada; Tremblay & Viger 1999) . Site-directed, serially arranged trinucleotide mutations were introduced in the HAMP promoter construct K1234/C73 bp using the QuikChange II XL mutagenesis kit (Stratagene, La Jolla, CA, USA) and oligonucleotides listed in Table 1 . All plasmids were verified by digestion with restriction enzymes and sequencing (McGill University and Génome Québec Innovation Centre). Expression vectors for GATA-1, GATA-3, GATA-4, GATA-6, FOG-1, and FOG-2 were kindly provided by Dr Robert Viger (CHUQ, Laval University) and have been described previously (Tremblay & Viger 1999 , Robert et al. 2002 .
Transfections and luciferase assays
Transfections of Huh7 cells were performed in 12-well plates using the Lipofectamine 2000 (Invitrogen) as recommended by the manufacturer. Briefly, on the day before transfection 8!10 4 hepatocytes were seeded with 1000 ml of antibiotic-free media per well. Hepatocytes were co-transfected with 1580 ng/well of either wild-type (WT) or mutated (MT) HAMP promoter constructs along with 20 ng of phRL-TK (Renilla Luciferase). Five hours after transfection, the media was replaced with fresh antibiotic-free media. Hepatocytes were lysed 40 h following transfection and the Dual-Luciferase Assay System (Promega Corporation) used to determine Luciferase activities (firefly and Renilla) with a TD-20/20 Luminometer (Turner Designs, Sunnyvale, CA, USA). When evaluating the effect of either GATA (1, 3, 4, and 6) or FOG (1 and 2) protein on the HAMP promoter, Huh7 cells were co-transfected with increasing concentrations (0-787 . 5 ng/well) of the expression vectors encoding the full-length GATA or FOG protein in addition to the HAMP reporter constructs (787 . 5 ng/well). The total amount of DNA was maintained at 1 . 6 mg/well by adding an empty pcDNA3 vector (Invitrogen). In all experiments, data reported represent an average of at least three experiments, done in triplicate, using at least three different DNA preparations.
In silico analysis
Analysis for potential regulatory elements (RE) in the HAMP promoter was performed using Evolutionary Conserved Regions ECR Browser (http://ecrbrowser. ) and the nuclear protein extracts prepared using a kit (Active Motif, Carlsbad, CA, USA). The probe used in electromobility shift assay (EMSA) was obtained by enzymatic labeling the 3 0 -end of a double-stranded oligonucleotide corresponding to the promoter region K121/K83 (Table 1 ) of the HAMP promoter by incorporation of a single digoxigenin (DIG)-labeled ddUTP using the DIG kit (Roche Diagnostics). Briefly, 100 pmol of the WT oligonucleotide was added (on ice) to 4 ml 5! labeling buffer, 4 ml, 25 mM CoCl 2 , 1 ml 0 . 05 mM DIG-11-ddUTP and 400 U terminal transferase in a final volume of 20 ml and then incubated at 37 8C for 15 min. The efficiency of the labeling was tested in a dot blot assay as described by the manufacturer (Roche Diagnostics). The probe (0 . 8 ng) was incubated with 7 . 5 mg of nuclear protein extracts from Huh7 cells along with 1 ml poly [d(I-C)], 0 . 1 mg poly-L-lysine in 20 ml of binding buffer for 15 min at room temperature. In the competition experiments, specific binding of nuclear protein extracts from Huh7 cells to the probe was challenged with an excess (125! and 250! molar excess) of unlabeled oligonucleotides (Table 1 ). The unlabeled oligonucleotides carried a sequence that corresponded to either the WT promoter region K121/K83 or a MT (an oligonucleotide bearing a mutation of the GATA-binding site -TATCT- (Table 1) ). In the super-shift experiments, the nuclear protein extracts that were used were prepared from Huh7 cells 40 h following their transfection with 24 mg of either an expression vector encoding the fulllength WT GATA protein (4 or 6) or the empty plasmid vector, pcDNA3 (Invitrogen). Specific binding of the nuclear extracts harvested from the transfected Huh7 cells to the probe was evaluated in the presence of either an antibody raised against the overexpressed protein (either GATA-4 or GATA-6) or in the presence of normal goat IgG. The latter was used as a control for the goat anti-human GATA-4 polyclonal antibody (Part 965831; R&D Systems, Inc., Minneapolis, MN, USA) and goat anti-human GATA-6 polyclonal antibody (Part 965812; R&D Systems, Inc.) that was used against overexpressed GATA-4 and GATA-6 proteins respectively. Aliquots of nuclear extracts harvested from Huh7 cells that had been transfected with the empty vector were incubated with either goat anti-human GATA-4 polyclonal antibody (Part 965831; R&D Systems, Inc.) or goat anti-human GATA-6 polyclonal antibody (Part 965812; R&D Systems, Inc.). Normal goat IgG (Part 965806; R&D Systems, Inc.) was used as a control for both the antibodies used.
All the DNA-protein mixtures above were migrated through a 6% polyacrylamide gel in 0 . 5!TBE at 84 V then transferred at 400 mA to a positively charged nylon membrane which was then probed for the DIGlabeled oligonucleotide with specific antibodies as recommended by the DIG-kit manufacturer (Roche Diagnostics).
Chromatin immunoprecipitation assay
Chromatin immunoprecipitation (ChIP) assays for GATA-4 and GATA-6 were performed as specified in the ExactaChiP Human GATA-4 and GATA-6 ChIP Kits, Catalog numbers ECP2606 and ECP1700, respectively (R&D Systems, Inc.), with a few modifications. In experiments for endogenous binding of GATA proteins 4 and 6 to the HAMP promoter, Huh7 cells were grown to 90% confluence in cell culture media containing 10% FBS. However, when evaluating the effect of IL6 on the binding of GATA proteins 4 and 6 to the HAMP promoter, Huh7 cells were grown to 80% confluence in cell culture media containing 10% FBS, the latter (FBS) was then withdrawn from the culture media for 10 h (overnight). The cell culture media was then replenished with fresh media free of FBS with or without IL6 (2 . 5 ng/ml) for 6 h. Cells (w1!10 7 cells per 100 mm petri dish) from both experiments were fixed using 1% formaldehyde and the chromatin sheared (w300-1000 bp) using a Misonix Ultrasonic XL-2000 Liquid Processor, by pulsing seven times for 23 s at a power output of 7 W with rest intervals on ice of 45 s between each pulse. The cross-linked protein-DNA samples were pre-cleared with a slurry of protein A plus protein G agarose beads (Catalog number: IP05; EMD Biosciences, Inc., Darmstadt, Germany), 1 mg/ml salmon sperm DNA (Cat 15632-011; Sigma-Aldrich) and 1 mg/ml BSA (Sigma-Aldrich). The samples were then immunoprecipitated using either goat anti-human GATA-4 polyclonal antibody (Part 965831; R&D Systems, Inc.) or goat anti-human GATA-6 polyclonal antibody (Part 965812; R&D Systems, Inc.), overnight at 4 8C while being gently swirled with a rotor. Normal goat IgG (Part 965806; R&D Systems, Inc.) was used as the control for the antibodies in the ChIP assay. The protein-DNA complexes were pulled using streptavidin-conjugated beads from Sigma-Aldrich as a stationary phase. In the PCRs, either 1/20 of the input chromatin used for the immunoprecipitation experiments or 50% (25 ml) of the total immunoprecipitated DNA was used as templates. Water and 10 ng of the fulllength HAMP promoter construct (K1234/C73) served as the PCR negative and positive controls respectively. Primers were utilized specific for the proximal region of the HAMP promoter region K155 to C73 bp (Table 1) . PCRs were carried out using Phusion high-fidelity DNA Polymerase (New England Biolabs, Pickering, Ontario, Canada) at 95 8C for 5 min, followed by 32 cycles of 94 8C for 1 min, 61 8C for 1 min, and 72 8C for 30 s and completed by a final extension of 5 min at 72 8C. The PCR products were then analyzed by electrophoresis on a 1 . 5% ethidium bromide-stained agarose gel. When evaluating the effect of IL6 on the binding of GATA proteins to the HAMP promoter, the PCRs were analyzed by densitometry. The readings taken on a gray scale were normalized to the input signal for each treatment (with or without IL6) and then binding was then expressed in relative arbitrary units.
Statistical analysis
The data were analyzed by a one-way ANOVA (SigmaStat Version 2.0, Jadel Corporation, San Rafael, CA, USA). Multiple range comparisons of paired means were done using a Fishers LSD test or the NewmanKeuls test. Level of significance was set at P!0 . 05. Data are reported as meanGS.E.M.
Results
Expression of HAMP in the liver and hepatoma cell lines
Reverse quantitative PCR was performed to evaluate the expression of hepcidin mRNA in the adult human liver and the hepatoma cell lines (Huh7 and HepG2). Using b-actin as a reference gene, the relative mRNA expression of HAMP was higher in Huh7 cells compared with either HepG2 cells or adult human liver, 3 . 7G0 . 4, 1 . 33G0 . 4, and 2 . 83G0 . 12 respectively (P!0 . 05). The presence of HAMP mRNA in the hepatoma cell lines indicates that these cell lines have the capacity to transcribe HAMP.
Localization of the regulatory elements of the HAMP promoter
To locate the regulatory elements (RE) important for transcription hepcidin in hepatocytes, a 1307 bp (K1234/C73) HAMP promoter along with 5 0 -deletion constructs were generated by from human genomic DNA. Promoter fragments of !1000 bp were shown to be sufficient to evaluate basal transcription of HAMP (Courselaud et al. 2002 , Bayele et al. 2006 , Verga Falzacappa et al. 2007 , Vecchi et al. 2009 ). Deletion of the HAMP promoter from K1234 to K1117 bp led to an increase in promoter activity in Huh7 cells (P!0 . 05; Fig. 1 ). Subsequent deletions from K932 to K878 bp and K816 to K155 bp decreased the HAMP promoter activity (P!0 . 05; Fig. 1 ). Promoter activity reached ebb following the deletion to K96 bp (P!0 . 05; Fig. 1 ).
The deletion from K816 to K155 bp lead to the removal of a C/EBPa bind site K231/K222 bp that was previously reported to be important for the basal HAMP promoter activity (Courselaud et al. 2002 , Verga Falzacappa et al. 2007 ). The drastic decrease in promoter activity that followed the deletion of the distal K932/K878 bp and proximal K155/K96 bp regions, indicated the removal of putative RE in the HAMP promoter that are crucial for high promoter activity under steady-state culture conditions.
Fine mapping of the regulatory regions in the human HAMP promoter
To better define the RE located within the distal (K932/K878) and proximal (K155/K96) promoter regions, sites I and II, respectively, we performed both in silico analysis and site-directed mutagenesis. Using the Transcription Factor SEARCH program to scan the region K932/K878 for potential regulatory elements, we found a A/T-rich region K918/K906 with the WT sequence -GCTATTACTATTA-is a potential CdxA-RE (Heinemeyer et al. 1998) . To further investigate the site, eight serially linked scanning mutations were introduced in the distal (K932/K878) HAMP promoter region ( Fig. 2A) . Each construct harbored a different tri-nucleotide mutation in the context of the K1234/ C73 construct. Tri-nucleotide mutations in constructs, M23, M24, and M25 decreased HAMP promoter activity compared with the WT construct (P!0 . 05; Fig. 2A ).
We did not investigate the effects of CdxA on HAMP promoter activity nor it's binding to the A/T-rich sequence since CdxA is not expressed in the normal liver (Gautier-Stein et al. 2003) . Ten mutants were generated by introducing serially arranged tri-nucleotide mutations in the proximal promoter region K143/K96 (site II) of the HAMP promoter, in the context of the K1234/C73 construct (Fig. 2B) . Transfection of the HAMP promoter constructs in Huh7 cells revealed mutations M3-M11 decreased the promoter activity compared with the WT promoter (P!0 . 05; Fig. 2B ). Site II, encompasses two subregions: a 13-nucleotide (K138/K125) and a 6-nucleotide A/T-rich (K103/K98). Using bioinformatics (ECR Browser and TFSEARCH) we established that the WT sequence -TGACACAACCCTG-in the subregion K138/K125, mutated in the promoter constructs M3-M5 was a CREB-RE (Vecchi et al. 2009 ); while the WT sequence -TTATCT-in the subregion K103/K98, mutated in the promoter in constructs M10 and M11 is a GATA-RE (Imagawa et al. 1997 , Robert et al. 2002 , Obara et al. 2008a . To see if the GATA-RE was crucial for the transcriptional activity of the HAMP promoter in HepG2 cells, M10, M11 and the WT constructs were transfected in the hepatoma cells. Mutations of either M10 or M11 decreased the promoter activity to 0 . 28G0 . 02 or 0 . 33G0 . 03, respectively, compared with the WT promoter activity (1 . 0, P!0 . 05).
GATA-and its co-factor FOG modulate the HAMP promoter activity
In silico analysis indicated that the GATA-RE in the proximal promoter site K103/K98 had a high probability of binding GATA proteins 1, 3, 4, and 6. We then determined if the GATA proteins 1, 3, 4, and 6 and its modulator protein FOG (1 and 2) were involved in the regulation of the HAMP promoter activity. Co-transfection of Huh7 cells with the HAMP promoter (K1234/C73) along with increasing concentrations of the expression vectors encoding GATA proteins 1, 4, and 6 led to a dose-dependent increase in the HAMP promoter activity (PO0 . 05; Fig. 3A-D) , while the co-transfection of Huh7 cells with the HAMP promoter construct K1234/C73 bp along with increasing concentrations (0-787 ng) of either FOG-1 or FOG-2 expression vector led to a dose-dependent suppression of the HAMP promoter activity (PO0 . 05; Fig. 3E and F).
We concluded that GATA proteins 1, 4, and 6 transactivate the HAMP promoter; while FOG proteins (1 and 2) suppress the activity.
FOG-1 and FOG-2 suppress the GATA-induced transactivation of the HAMP in Huh7 cells
The transactivation capacity of GATA-factors is modulated by their co-factor FOG proteins 1 and 2 , Robert et al. 2002 , Obara et al. 2008a .
To establish if FOG-1 and FOG-2 suppressed the exogenous GATA-induced transactivation of HAMP we co-transfected Huh7 cells with the HAMP promoter construct K1234/C73 bp along with expression vectors of either GATA-1 (400 ng/well) or GATA-4 (200 ng/well) or GATA-6 (400 ng/well) in combination with increasing concentrations (0-787 ng/well) of expression vectors encoding FOG proteins (1 or 2). FOG-1 and FOG-2 suppressed the exogenous GATA proteins 1, 4, and 6 transactivation of the HAMP (PO0 . 05; Fig. 4A and B) . GATA transactivation of the HAMP is dependent on a GATA-RE in the proximal promoter region
To evaluate whether the transactivation of the HAMP promoter was dependent on a GATA-RE in the promoter region K103/K98 we co-transfected Huh7 cells with different HAMP promoter constructs (M10 and deletion constructs K1234/C73, K816/ C73, K155/C73, and K96/C73) along with expression vectors encoding GATA proteins 1, 4, and 6 ( Fig. 5A-C) . The GATA-RE in the proximal HAMP promoter region K103/K98 bp was mutated and deleted in constructs M10 and K96/C73 bp respectively. Mutation or deletion of the GATA-RE sequence blunted the exogenous GATA-1, GATA-4, and GATA-6 transactivation of the HAMP promoter in Huh7 cells (Fig. 5A-C) . The transactivation of the HAMP by GATA proteins 1, 4, and 6 is therefore dependent on the presence of a GATA-RE in proximal promoter region (K103/K98).
Expression of GATA-factors in adult human liver and hepatoma cell lines
To determine which of the GATA (1-6) and FOG (1 and 2) factors are relevant for the transcription of HAMP under steady cell culture conditions, we used in addition expression plasmids encoding either GATA-1 (400 ng/well) or GATA-4 (200 ng/well) or GATA-6 (400 ng/well, A and B). To evaluate the basal firefly luciferase activity for controls the WT HAMP promoter (K1234/C73) was co-transfected with the empty expression vector (pcDNA3; Invitrogen). Total DNA concentration transfected was kept at 1600 ng/well in 12-well plates by adding an empty vector (pcDNA3; Invitrogen). At least three experiments were done in triplicate using three different DNA preparations for each construct. The relative luciferase activities of the treatments were determined with respect to the basal firefly luciferase activity of the promoter fragment K1234/C73 (meanGS.E.M.). A different superscript indicates a significant difference in fold suppression ( a-n P!0 . 05).
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quantitative RT-PCR to determine their expression in the adult human liver and hepatocytes. We established that mRNA for GATA-factors 2, 3, 4, and 6, as well as FOG-1 and FOG-2 are present in the adult human liver and Huh7 cells although the levels of FOG-2 mRNA were almost undetectable in Huh7 (Fig. 6 ). HepG2 cells expressed GATA-2, GATA-4, and GATA-6, as well as FOG-1 mRNA but GATA-3 and FOG-2 were undetectable in HepG2 cells (Fig. 6 ). We were unable to detect GATA-1 and GATA-5 mRNA in the adult human liver and the hepatoma cells.
Several proteins bind to the proximal promoter region K121/K83 of the HAMP promoter An EMSA was performed by nuclear extracts from Huh7 cells and a probe that spanned the region K121/K83 bp of the HAMP promoter to determine whether the DNA-protein binding was specific ( Fig. 7A and GATA-1 Figure 5 The GATA transactivation of HAMP is dependent on a GATA-regulatory element in the proximal promoter region. Huh7 cells were co-transfected with 787 . 5 ng/well of either full-length K1234/C73 bp wild-type or a mutant HAMP promoter (carrying a mutated GATA-RE) or 5 0 -deletion constructs as shown to the left of the y-axis along in addition with either expression plasmids encoding full-length GATA-1 (400 ng/well, A) or GATA-4 (200 ng/well, B) or GATA-6 (400 ng/well, C). To evaluate the control or basal firefly luciferase activity of every HAMP promoter construct, each promoter construct was co-transfected with the empty vector (pcDNA3; Invitrogen). Total DNA concentration transfected was kept at 1600 ng/well in 12-well plates by adding the empty vector (pcDNA3). At least three experiments were done in triplicate using three different DNA preparations for each construct. Results are the relative firefly luciferase activity of the co-transfected cells with respect to the same HAMP promoter co-transfected with only the empty vector (pcDNA3; mean
GS.E.M.).
A different superscript indicates a significant difference between means ( a-h P!0 . 05). Figure 6 The expression of GATA (2, 3, 4, and 6; panels A-D) and FOG (1 and 2; panels E and F) in the human liver and hepatoma cell lines. Total RNA from hepatocytes was isolated using TRizol (Invitrogen Canada). An aliquot of the total RNA (2 mg) was used as a template to synthesize the first-strand cDNA using the Omniscript reverse transcriptase-PCR system (Qiagen), 5 ml of diluted cDNA (1:6) was then used as a template in the RT-PCRs. Quantification of gene expression was performed by a Rotor Gene 3000 Real-time DNA Detection System (Montreal Biotech, Kirkland, QC, Canada) with QuantiTect SYBRGreen I PCR kits (Qiagen). Amplifications were performed in duplicate using at least three different preparations of first-strand cDNAs for each of the three different RNA extractions while adult human liver total RNA was purchased from Clontech Laboratories, Inc. Expression levels for GATA (dark gray bars) and FOG (light gray bars) were normalized to the housekeeping gene b-actin. The results are presented as mean (GS.E.M.) of the relative mRNA expression. A different superscript indicates a statistically significant difference between means ( a-l displaced all the protein-DNA complexes (Fig. 7B,  lanes 3 and 4) , while increased concentrations (125! and 250!) of oligonucleotide harboring the mutated GATA-RE at the site K103/K98 (Table 1) , was unable to compete with the probe in the formation of complex II; however, it effectively outcompeted the WT probe for nuclear protein binding in the formation of complexes I and III ( Fig. 7B ; lanes 5 and 6).
GATA-4 and GATA-6 bind to the proximal promoter region of the HAMP Since the sequence -TTATCT-is a putative GATAbinding site for nuclear proteins isolated from Huh7 cells that when mutated compromises the ability of nuclear proteins to specifically bind to the DNA (Imagawa et al. 1997 , Robert et al. 2002 , Obara et al. 2008a , we decided to confirm if GATA proteins 4 and 6 bind to the GATA-RE at K103/K98 of the HAMP promoter. Binding of the probe was performed with nuclear extracts that were harvested from Huh7 cells following overexpression of either GATA-4 (Fig. 7C, lanes 4 and 5) or GATA-6 (Fig. 7C, lanes 8 and 9) protein in the presence of either an antibody directed toward the overexpressed GATA protein (anti-GATA-4 (Fig. 7C, lane 5) or anti-GATA-6 (Fig. 7C, lane 9) ) or normal goat serum, the latter was a control for each of the antibodies used (Fig. 7C, lanes 4 and 8) . Nuclear extracts collected from Huh7 cells that overexpressed either GATA-4 or GATA-6 incubated with the probe in presence normal goat serum showed a bigger complex II (Fig. 7C , lanes 4 and 6) than the control nuclear extracts that were collected form Huh7 cells transfected with the empty vector pCDNA3 (Invitrogen) and then incubated with the probe in presence of normal goat serum ( Table 1 . To evaluate binding of GATA proteins to the HAMP promoter (C) nuclear protein extracts 7 . 5 mg) were prepared from Huh7 cells 40 h following transfection with 24 mg of either an expression vector encoding the full-length WT GATA protein (GATA-4 (C, lanes 4 and 5) or GATA-6 (C, lanes 8 and 9)) or an empty plasmid vector (pcDNA3 (C, lanes 2, 3, 6, and 7)). Specific binding to a double-stranded DIG-labeled oligonucleotide corresponding to the WT promoter region K121/K83 bp of the HAMP gene (A) of nuclear extracts from Huh7 cells overexpressing either GATA-4 (C, lanes 4 and 5) or GATA-6 (C, lanes 8 and 9) protein was evaluated in the presence of either an antibody directed toward the overexpressed GATA protein (anti-GATA-4 (C, lane 5) or anti-GATA-6 (C, lane 9)) or normal goat serum as a control (C, lanes 4 and 8). Overexpressed GATA protein (4 or 6) incubated with the probe in presence normal goat serum showed a bigger complex II (C, lanes 4 and 6) than control nuclear extracts collected from Huh7 cells transfected with an empty vector [pCDNA3] that were incubated with the probe in presence of normal goat serum (C, lanes 2 and 6). Complex II was abrogated by incubation of the probe with nuclear extracts containing the overexpressed GATA protein along with an antibody directed against the corresponding overexpressed protein (goat antihuman GATA-4 polyclonal antibody or goat anti-human GATA-6 polyclonal antibody for GATA proteins 4 or 6, respectively), as shown in C, lane 5 (in the case of GATA-4) or lane 9 (in the case of GATA-6).
Systems, Inc.) in case of GATA-4 or goat anti-human GATA-6 polyclonal antibody (Part 965812; R&D Systems, Inc.) in the case of GATA-6) abrogated complexes I and II while having no effect on complex III, as shown in Fig. 7C , lane 5 (in the case of GATA-4) and lane 9 (in the case of GATA-6) compared with when normal goat IgG was used in place of the antibody, Fig. 7C , lane 4 (anti-GATA-4) and lane 8 (anti-GATA-6).
The data indicate that complex II corresponds to GATA-4 and GATA-6, since mutation of the GATA-RE failed to displace complex II that was subsequently abrogated by anti-GATA-4 and anti-GATA-6 antibodies respectively ( Fig. 7B and C) .
To confirm the recruitment of GATA-4 and GATA-6 to the proximal HAMP promoter in vivo, a ChIP assays were performed with antisera for GATA-4 and GATA-6. In Fig. 8A , a band of the expected size (w230 bp) corresponding to the proximal HAMP promoter was detected in the samples immunoprecipitated with the antisera against GATA-4 (Fig. 8A, lane 3) and GATA-6 (Fig. 8A, lane 4) which indicated that both GATA-4 and GATA-6 are associated with the proximal HAMP promoter in Huh7 cells. Treatment of Huh7 cells with 2 . 5 ng/ml of IL6 for 6 h increased the binding of GATA proteins 4 and 6 to the proximal HAMP promoter (Fig. 8B) .
We concluded that in Huh7 cells, endogenous GATA-factors 4 and 6 are the cell-specific transcription factors involved in the transcriptional regulation of HAMP; while FOG-1 modulates the GATA-4 and GATA-6 induced transcription of HAMP through the GATA-RE in the proximal HAMP promoter region.
Discussion
In this study, HAMP mRNA was detected in both Huh7 and HepG2 cells, which indicated that the cell lines had the capacity to transcribe hepcidin. Promoter analysis in Huh7 cells revealed an increase in promoter activity when the 5 0 -end of the HAMP promoter fragment was deleted from K1234 to K1117 bp. The increase in activity may have been due to elimination of repressive elements upstream of K1117 bp. The presence of alternating d(TG)n-type purine-pyrimidine di-nucleotide repeats in the deleted region could have suppressed the HAMP promoter activity (Naylor & Clark 1990 , Bergeron et al. 2011 ; however, in silico analysis of the deleted region revealed a potential CP-2 transcription factor binding site K1191/K1181 with a WT sequence -GGCCATGCCCT- (Heinemeyer et al. 1998) . CP-2 is expressed in hepatocytes and acts either as a transcription enhancer or repressor (Veljkovic & Hansen 2004 , Jang et al. 2010 . CP-2 binds to the transferrin promoter and upregulates its transcription (Jang et al. 2010) . High levels of transferrin and CP-2 occur in concert with the downregulation of hepcidin during iron deficiency anemia (Macedo & de Sousa 2008) . However, during inflammation high levels of hepcidin are coincident with the downregulation of transferrin and CP-2 (Ritchie et al. 1999 ) and as such, CP-2 might be a transcriptional repressor of HAMP. The transcription of HAMP in hepatocytes . E T BAGU and M M SANTOS 309
www.endocrinology-journals.orgthroughtheC/EBPsiteK231/K222 (Nicolasetal.2002) . It is not clear as to how the physiological changes in concentration of iron or oxygen tension in blood affect either FOG or GATA and subsequently hepcidin. In HepG2 cells, the concentration of GATA-4 was neither affected by proinflammatory cytokines (IL1b and tumor necrosis factor-a) nor hypoxia (Dame et al. 2004) . In this study, we noted an increased binding of GATA proteins (4 and 6) to the HAMP promoter in Huh7 cells following treatment with IL6 as such it is likely that during inflammation the increased recruitment of GATA proteins to the HAMP promoter contributes to the higher expression of hepcidin in hepatocytes. IL6 is a proinflammatory cytokine responsible for the increased expression of HAMP during inflammation or following treatment with lipopolysaccharide (Andrews 2004 ). While the current manuscript was under review, Island et al. (2011) reported that in HepG2 cells mutation of the GATA-RE impaired the IL6 induction of hepcidin gene expression, but did not prevent the response to BMP6. They suggested that GATA-4 could be involved in the control of hepcidin expression and that alteration of its expression may contribute to the development of iron-related disorders (Island et al. 2011) . Incidentally, GATA-4 was shown to be absent in hepatocytes that were isolated from normal mice and humans during the postnatal period (Dame et al. 2004 , Divine et al. 2004 . The absence of GATA-4 in hepatocytes during the postnatal period was also cited as the reason for the switch in the expression of the EPO gene from fetal hepatocytes to the adult kidney in mice and humans (Dame et al. 2004) . The changes in concentrations of the proinflammatory cytokines (IL6) in the body during the postnatal period may therefore affect levels of either GATA-6 or FOG protein (1 and 2) in hepatocytes and the nature of the response being dependent on the type and strength of the input signal: the increase in GATA-6 with or without a decrease in FOG upregulating the transcription of HAMP; while the increase in concentration of FOG proteins with or without a decrease in GATA-6 concentrations downregulating the transcription of HAMP. In mice, inactivation of either GATA (4 and 6) or FOG (1 and 2) causes embryonic death, hindering in vivo assessment of the role of transcriptional factors in the expression of hepcidin in hepatocytes (Kuo et al. 1997 , Molkentin et al. 1997 , Zhao et al. 2005 .
In this study, we concluded that the GATA regulatory region in the proximal HAMP promoter is important for the basal expression of hepcidin in hepatocytes, GATA-factors 4 and 6 bind to the GATA-RE -TTATCTin the promoter region K103/K98 and upregulate the transcription of HAMP, while FOG through its ability to suppress both the endogenous and exogenous GATA-induced transcription of HAMP acts as an alternative port for the regulation of hepcidin.
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